251 related articles for article (PubMed ID: 31792089)
21. Characteristics of Primary and Metachronous Gastric Cancers Discovered after
Maehata Y; Nakamura S; Esaki M; Ikeda F; Moriyama T; Hida R; Washio E; Umeno J; Hirahashi M; Kitazono T; Matsumoto T
Gut Liver; 2017 Sep; 11(5):628-634. PubMed ID: 28395508
[TBL] [Abstract][Full Text] [Related]
22. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication.
Arai J; Miyawaki A; Aoki T; Niikura R; Hayakawa Y; Fujiwara H; Ihara S; Fujishiro M; Kasuga M
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1217-1225.e6. PubMed ID: 38354970
[TBL] [Abstract][Full Text] [Related]
23. Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies.
Lin CJ; Liao WC; Lin HJ; Hsu YM; Lin CL; Chen YA; Feng CL; Chen CJ; Kao MC; Lai CH; Kao CH
PLoS One; 2016; 11(1):e0146432. PubMed ID: 26730715
[TBL] [Abstract][Full Text] [Related]
24. Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey.
Hata K; Ito M; Boda T; Kotachi T; Kiso M; Masuda K; Kurihara M; Kuroki K; Yorita N; Nagasaki N; Abduwali M; Tanaka S; Chayama K
Digestion; 2019; 99(1):59-65. PubMed ID: 30554223
[TBL] [Abstract][Full Text] [Related]
25. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH
N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147
[TBL] [Abstract][Full Text] [Related]
27.
Doorakkers E; Lagergren J; Engstrand L; Brusselaers N
Gut; 2018 Dec; 67(12):2092-2096. PubMed ID: 29382776
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
29. Effects of
Li WQ; Zhang JY; Ma JL; Li ZX; Zhang L; Zhang Y; Guo Y; Zhou T; Li JY; Shen L; Liu WD; Han ZX; Blot WJ; Gail MH; Pan KF; You WC
BMJ; 2019 Sep; 366():l5016. PubMed ID: 31511230
[TBL] [Abstract][Full Text] [Related]
30. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
[TBL] [Abstract][Full Text] [Related]
31. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
Kim N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
[TBL] [Abstract][Full Text] [Related]
33. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
34. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
Kim CG; Song HJ; Kook MC; Hong EK; Park S; Lee JY; Lee JH; Ryu KW; Kim YW; Bae JM; Choi IJ
Am J Gastroenterol; 2008 Jan; 103(1):48-54. PubMed ID: 17714557
[TBL] [Abstract][Full Text] [Related]
35. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan.
Uno Y
Cancer Med; 2019 Jul; 8(8):3992-4000. PubMed ID: 31119891
[TBL] [Abstract][Full Text] [Related]
36. Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication.
Leung WK; Cheung KS; Li B; Law SYK; Lui TKL
Aliment Pharmacol Ther; 2021 Apr; 53(8):864-872. PubMed ID: 33486805
[TBL] [Abstract][Full Text] [Related]
37. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
38. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects and benefits of
Chen J; Zhang G; Qin J; Huang Y; Wang Y; Li Z; Ji D; Xiao L; Yin S; Bao Z
Saudi J Gastroenterol; 2022; 28(2):149-156. PubMed ID: 35083971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
